Mid Cap Insider Buying: Noble Corp. (NYSE:NE), WPX Energy (NYSE:WPX), DSW (NYSE:DSW), Opko Health (NYSE:OPK), Seattle Genetics (NASDAQ:SGEN)

Noble Co. (NYSE:NE) CEO David W. Williams bought 10,000 shares of the stock on the open market in a transaction that occurred on Friday, June 6th. The stock was purchased at an average price of $31.03 per share, with a total value of $310,300.00. Following the completion of the purchase, the chief executive officer now directly owns 390,282 shares of the company’s stock, valued at approximately $12,110,450. Noble Corp. (NYSE:NE) stock performance was 0.38% in last session and finished the day at $31.89. Traded volume was 3.76million shares in the last session and the average volume of the stock remained 3.83million shares. The beta of the stock remained 1.49. Noble Corp. (NYSE:NE) insider ownership is 0.60%.

WPX Energy (NYSE:WPX) CEO Richard E. Muncrief acquired 14,000 shares of the stock in a transaction dated Monday, June 9th. The shares were purchased at an average price of $21.71 per share, with a total value of $303,940.00. Following the completion of the purchase, the chief executive officer now directly owns 14,000 shares in the company, valued at approximately $303,940. WPX Energy Inc (NYSE:WPX) dropped -0.42 percent to $21.46 Tuesday on volume of 2.77million shares. The intra-day range of the stock was $21.35 to $21.65. WPX Energy Inc (NYSE:WPX) has a market capitalization of $4.34billion.

DSW Inc (NYSE:DSW) SVP Mary E. Meixelsperger acquired 2,000 shares of DSW stock on the open market in a transaction dated Wednesday, June 4th. The shares were purchased at an average price of $25.94 per share, for a total transaction of $51,880.00. Following the completion of the purchase, the senior vice president now directly owns 4,000 shares in the company, valued at approximately $103,760. DSW Inc. (NYSE:DSW)’s stock on June 10, 2014 reported a decrease of -0.29% to the closing price of $27.54. Its fifty two weeks range is $23.45 -$47.55. The total market capitalization recorded $2.50billion. The overall volume in the last trading session was 2.21million shares. In its share capital, DSW has 90.55million outstanding shares.

Opko Health Inc (NYSE:OPK) CEO Phillip Md Et Al Frost acquired 20,000 shares of Opko Health stock on the open market in a transaction dated Wednesday, June 4th. The stock was purchased at an average cost of $8.78 per share, for a total transaction of $175,600.00. Following the completion of the acquisition, the chief executive officer now directly owns 1,987,500 shares in the company, valued at approximately $17,450,250. On Tuesday, shares of Opko Health Inc. (NYSE:OPK) dropped -1.50% to close the day at $9.21. Company return on investment (ROI) is -8.10% and its monthly performance is recorded as 11.77%.  Opko Health Inc. (NYSE:OPK) quarterly revenue growth is 0.77%.

Seattle Genetics, Inc (NASDAQ:SGEN) Director Felix Baker purchased 281,963 shares of Seattle Genetics stock in a transaction dated Wednesday, June 4th. The stock was purchased at an average price of $34.86 per share, for a total transaction of $9,829,230.18. Following the transaction, the director now directly owns 76,997 shares of the company’s stock, valued at approximately $2,684,115. Seattle Genetics, Inc. (NASDAQ:SGEN) stock performance was 3.78% in last session and finished the day at $40.08. Traded volume was 1.48million shares in the last session and the average volume of the stock remained 1.17million shares. The beta of the stock remained 1.38. Seattle Genetics, Inc. (NASDAQ:SGEN) insider ownership is 1.40%.